Alberta Investment Management Corp (AIMCo)’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-7,323
Closed -$4.11M – 835
2020
Q4
$4.11M Sell
7,323
-1,075
-13% -$681K 0.04% 416
2020
Q3
$5.87M Hold
8,398
– – 0.06% 337
2020
Q2
$6.64M Buy
8,398
+1,339
+19% +$1.01M 0.08% 289
2020
Q1
$4.2M Buy
7,059
+1,318
+23% +$1.28M 0.07% 291
2019
Q4
$6.53M Buy
5,741
+1,932
+51% +$2.1M 0.06% 304
2019
Q3
$4.53M Buy
3,809
+1,961
+106% +$2.99M 0.04% 357
2019
Q2
$3.04M Buy
+1,848
New +$3.2M 0.03% 421

Other funds holding BLUE

Alberta Investment Management Corp (AIMCo)'s BLUE Position: Q1 2021 in Review

Alberta Investment Management Corp (AIMCo) sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 7,323 shares — an estimated $4.11M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in BLUE in Q2 2019 and held it in 7 quarters. The position peaked at $6.64M in Q2 2020. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.

  • Alberta Investment Management Corp (AIMCo) reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 7,323 bluebird bio shares in Q1 2021, an estimated $4.11M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in bluebird bio in Q2 2019 and held it in 7 quarters.
  • Alberta Investment Management Corp (AIMCo)'s bluebird bio position peaked at $6.64M in Q2 2020.
  • 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2021, filed 7 May 2021.